R. F. Sidonio Et Al. , "Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a," BLOOD , vol.138, 2021
Sidonio, R. F. Et Al. 2021. Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a. BLOOD , vol.138 .
Sidonio, R. F., Thompson, A. A., Peyvandi, F., Albayrak, C., Yeoh, S. L., Lam, J., ... Maggiore, C.(2021). Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a. BLOOD , vol.138.
Sidonio, Robert Et Al. "Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a," BLOOD , vol.138, 2021
Sidonio, Robert F. Et Al. "Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a." BLOOD , vol.138, 2021
Sidonio, R. F. Et Al. (2021) . "Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a." BLOOD , vol.138.
@article{article, author={Robert F. Sidonio Et Al. }, title={Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a}, journal={BLOOD}, year=2021}